510(k) Report

510(k) · Cleared

Cleared

Leksell Gammaplan 4C with Multiview

K042269510(k) SpecialCleared Sep 8, 200416-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Elekta Instrument AB · MUJ System, Planning, Radiation Therapy Treatment

Cleared on Sep 8, 2004 as substantially equivalent to K973441 (Patterson Consulting Group, Inc., 1998) after a 16-day review. Its family tree reaches back 2 generations to 1992. 11 later devices descend from it.

Decided
Sep 8, 2004
Review
16 days
Class
Class II
Product code
MUJ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K914808 (1992). 11 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2009: 2 descendants cleared2005: 1 descendant cleared2006: 1 descendant cleared2010: 2 descendants cleared2015: 1 descendant cleared2018: 1 descendant cleared2020: 1 descendant cleared2024: 1 descendant cleared2023: 1 descendant clearedK914808 · Leksell Gammaplan (LGP) · Elekta Instruments, Inc. · 1992K973441 · Leksell Gammaplan · Patterson Consulting Group, Inc. · 1998 · recalled1990200020102020
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 2 descendants3 generations forward: 2 descendants4 generations forward: 2 descendants5 generations forward: 2 descendants6 generations forward: 1 descendant K973441 · Leksell Gammaplan · Patterson Consulting Group, Inc. · 1998 · recalledK914808 · Leksell Gammaplan (LGP) · Elekta Instruments, Inc. · 19920+5
  1. Root · 2 generations backK914808 Leksell Gammaplan (LGP)Elekta Instruments, Inc. · 1992
  2. 1 generation backK973441 Leksell GammaplanPatterson Consulting Group, Inc. · 1998 · Recalled
  3. This deviceK042269 Leksell Gammaplan 4C with MultiviewElekta Instrument AB · 2004
  4. Descendant · cites it directly · 10 of its ownK051022 GammaplanElekta Instrument AB · 2005
  5. Descendant · 2 generations on · 9 of its ownK061540 Leksell GammaplanElekta Instrument AB · 2006
  6. Descendant · cites it directly · 6 of its ownK090972 Leksell GammaplanElekta Instrument AB · 2009
  7. Descendant · 2 generations on · 5 of its ownK103093 Leksell GammaplanElekta Instrument AB · 2010 · Recalled
  8. Descendant · 3 generations on · 4 of its ownK151666 Leksell GammaPlanElekta Instrument AB · 2015 · Recalled

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2005: 12006: 12009: 22010: 22015: 12018: 12020: 12023: 12024: 1
2005high 2 (2009) · low 0 (2007)2026

Most influential descendants

Showing 5 of 11 · See all
  • K051022GammaplanElekta Instrument AB · 2005 · cites it directly10descendants
  • K061540Leksell GammaplanElekta Instrument AB · 2006 · 2 generations on9descendants
  • K090972Leksell GammaplanElekta Instrument AB · 2009 · cites it directly6descendants
  • K103093Leksell GammaplanElekta Instrument AB · 2010 · 2 generations on5descendants
  • K151666Leksell GammaPlanElekta Instrument AB · 2015 · 3 generations on4descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K914808Leksell Gammaplan (LGP)Elekta Instruments, Inc.1992—
−1K973441Leksell GammaplanPatterson Consulting Group, Inc.19984
0 (this device)K042269Leksell Gammaplan 4C with MultiviewElekta Instrument AB2004—
+1K051022GammaplanElekta Instrument AB2005—
+2K061540Leksell GammaplanElekta Instrument AB2006—
+1K090972Leksell GammaplanElekta Instrument AB2009—
+2K103093Leksell GammaplanElekta Instrument AB20101
+3K151666Leksell GammaPlanElekta Instrument AB20151

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200610
200920
201020
201510
201810
202010
202310
202410
FIG. 1 — Lineage of K042269, 1992–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUJ device

  1. #1 K232799 syngo.via RT Image Suitescore 18.6 · 19 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K973441Leksell Gammaplan
Summary page 1
…ode |Class Regulation Number Radionuclide radiation therapy system |IWB [ 892.5750 4. Regulatory History (Unmodified Predicate Device) Devices 510(k) # Leksell GammaPlan K973441 5. Other relevant submissions Devices 510(k) # Leksell Surgiplan with Atlaspace K013861 Leksell Surgiplan with Imagemerge K033340…
Patterson Consulting Group, Inc.19984

Also cleared against K973441: 3 other devices →

What descends from it? (11)

See all 11

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K051022GammaplanElekta Instrument AB200510
K090972Leksell GammaplanElekta Instrument AB20096

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 6.4 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K051022 (Elekta Instrument AB, 2005) has gone furthest, with 10 descendants of its own.
  • 3 other devices also cite its predicate K973441.

How does its category compare?

All MUJ devices

MUJ System, Planning, Radiation Therapy Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MUJ

10in 2025

2007: 42008: 92009: 162010: 112011: 92012: 82013: 52014: 92015: 132016: 52017: 72018: 72019: 92020: 92021: 112022: 82023: 102024: 92025: 102026 (partial year): 9
2007high 16 (2009) · low 4 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUJ

186in 2025

2007: 67 days median2008: 63 days median2009: 84 days median2010: 56 days median2011: 103 days median2012: 59 days median2013: 64 days median2014: 108 days median2015: 78 days median2016: 80 days median2017: 30 days median2018: 53 days median2019: 56 days median2020: 104 days median2021: 87 days median2022: 168 days median2023: 140 days median2024: 122 days median2025: 186 days median2026 (partial year): 233 days median
2007high 233 (2026) · low 30 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUJ

2in 2023

2007: 42008: 102009: 112010: 232011: 172012: 42013: 62014: 22015: 72016: 132017: 42018: 32019: 42020: 22021: 42022: 32023: 22026 (partial year): 2
2007high 23 (2010) · low 0 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUJ

21in 2025

2007: 242008: 512009: 242010: 782011: 732012: 392013: 332014: 352015: 302016: 272017: 162018: 252019: 252020: 262021: 152022: 222023: 762024: 92025: 21
2007high 78 (2010) · low 9 (2024)2025

MAUDE reports naming product code MUJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007467424
20089631051
200916841124
201011562378
201191031773
2012859439
2013564633
20149108235
20151378730
20165801327
2017730416
2018753325
2019956425
20209104226
20211187415
20228168322
202310140276
2024912209
202510186021
202692332—

What is it indicated for?

The Leksell GarmmaPlan 4C with MultiView is a computer-based dose planning system specifically designed for use with the Leksell Gamma Knife®. The Leksell GammaPlan 4C with MultiView is intended to be used for planning the dosimetry of treatments in stereotactic radiosurgey and stereotactic radio therapy. It processes the inputs from the healt care professionals such that the desired radiation dose is provided by the Leksell Gamma Knife® to a precisely defined target area within the cranium.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K042269: Leksell Gammaplan 4C with Multiview.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K042269

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026